← Signals · Healthcare · TSX
$CHLT
Custom Health Holdings Inc.
Signal as of October 14, 2026  ·  90-day rolling window  ·  Healthcare Providers & Services
Confluence Score
47
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 40–59 have historically hit 41% of the time (avg +7.1% over 90 days, 4424 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
Confluence Score
47
Insider Activity (90d)
4
2 buyers  ·  $70K  ·  open-market only
Current Price
$6.00
CAD  ·  5-min cache
Market Cap
$157M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Healthcare on Form55: 54% hit rate · -3.8% alpha vs XIU.TO · 28 closed signals Track Record →
★
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSX:CHLT
Insider Transactions
90-day window  ·  6 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Oct 14, 2026 Aertker, Andrew — Open Market Buy 4,000 $7.25 -17.2%  · 7d $29K
Sep 04, 2026 Castanho, Michael — Open Market Sell 2,500 — — —
Sep 04, 2026 Castanho, Michael — Open Market Sell 2,500 $7.22 — $18K
Aug 25, 2026 Knight, Kevin George — Open Market Buy 3,500 $7.31 -17.9%  · 57d $26K
Aug 24, 2026 Knight, Kevin George — Open Market Buy 1,500 $7.07 -15.1%  · 58d $11K
Aug 24, 2026 Knight, Kevin George — Open Market Buy 700 $7.00 -14.3%  · 58d $5K
Score uses open-market buys only  ·  4 open-market  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 25 30 2 unique buyers
Buy/sell ratio 20 67% buys (4B / 2S)
Dollar value 25 $70K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 47 100
Unlock Component Detail — CAD $29/mo
Buying Insiders
Open-market · 90 days · 2 unique buyers
Insider Credibility Hit Rate Avg 90d Return Trades (eval'd) Buy Value (90d) Last Buy
Knight, Kevin George — — — — $41K Aug 25, 2026
Aertker, Andrew — — — — $29K Oct 14, 2026
Credibility score: historical hit rate × avg 90d return × sample size. View full insider leaderboard →
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for CHLT.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Sep 30, 2026
Shares short
27,467
Net change
-3,264 (-10.6%)
History
Sep 30: 27,467
Sep 15: 30,731
Aug 31: 39,377
Aug 15: 23,408
Jul 31: 12,122
Jul 15: 22,789
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Boardroom Connections
1 insider also active elsewhere
Insider Other boards Also an insider at
Castanho, Michael 1 SASK (70)
People who file as insiders here and at other TSX/TSXV companies (number in brackets = that company's Confluence Score). A well-connected insider taking a seat at a new junior can be an early tell. Matched by name across SEDI filings; funds and 10%+ holders excluded.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.